期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
自拟补肾促孕方联合来曲唑治疗肾阴虚型多囊卵巢综合征不孕症效果观察 被引量:14
1
作者 吕雪梅 刘锦云 +3 位作者 杨慧军 范媛媛 董云玲 贾婷 《山东医药》 CAS 2022年第4期59-62,共4页
目的观察自拟补肾促孕方联合来曲唑治疗肾阴虚型多囊卵巢综合征不孕症的临床疗效。方法选择肾阴虚型多囊卵巢综合征不孕症患者52例,随机分为治疗组26例和对照组26例。经过前期规范治疗达到促排卵标准,治疗组采用自拟补肾促孕方+来曲唑... 目的观察自拟补肾促孕方联合来曲唑治疗肾阴虚型多囊卵巢综合征不孕症的临床疗效。方法选择肾阴虚型多囊卵巢综合征不孕症患者52例,随机分为治疗组26例和对照组26例。经过前期规范治疗达到促排卵标准,治疗组采用自拟补肾促孕方+来曲唑方案联合促排卵助孕治疗,对照组采用六味地黄丸+来曲唑方案联合促排卵助孕治疗,3个促排卵周期为1个疗程。观察两组治疗前后肾阴虚证候评分,HCG日子宫内膜厚度、形态及性激素水平,累计临床妊娠率和早期自然流产率。结果两组治疗后肾阴虚证候评分均较治疗前降低(P均<0.01),且治疗组治疗后肾阴虚证候评分低于对照组(P<0.05)。治疗组HCG日子宫内膜厚度大于对照组,形态优于对照组,雌二醇水平高于对照组(P均<0.05)。治疗组、对照组累计妊娠率分别为50.0%(13/26)、34.62%(9/26),早期自然流产率分别为7.69%(1/13)、11.11%(1/9),两组比较P均>0.05。结论自拟补肾促孕方联合来曲唑可以改善由多囊卵巢综合征引起的不孕症患者肾阴虚临床证候,改善HCG日子宫内膜厚度及形态,可在一定程度提高患者累计临床妊娠率。 展开更多
关键词 多囊卵巢综合征 阴虚 临床妊娠率 自拟补肾促孕方 来曲唑
下载PDF
补肾促孕方联合人工授精治疗排卵性障碍不孕症疗效观察 被引量:2
2
作者 吕雪梅 刘锦云 +2 位作者 王苏梅 董云玲 魏斌 《山东中医杂志》 2012年第9期646-648,共3页
目的 :观察补肾促孕方联合宫腔内人工授精治疗排卵性障碍不孕症的疗效。方法 :将50例患者,分为治疗组26例(补肾促孕方+LE/HMG+IUI),对照组24例(LE/HMG+IUI),观察两组的妊娠率。结果:治疗组的妊娠率高于对照组,两组比较有显著性差异(P<... 目的 :观察补肾促孕方联合宫腔内人工授精治疗排卵性障碍不孕症的疗效。方法 :将50例患者,分为治疗组26例(补肾促孕方+LE/HMG+IUI),对照组24例(LE/HMG+IUI),观察两组的妊娠率。结果:治疗组的妊娠率高于对照组,两组比较有显著性差异(P<0.05)。结论:补肾促孕方可以提高夫精人工授精的临床妊娠率。 展开更多
关键词 补肾促孕方 宫腔内人工授精 排卵性障碍不 妊娠率
下载PDF
补肾促孕方改善大鼠子宫内膜容受性的药效及成分研究 被引量:2
3
作者 江媚 王春国 +2 位作者 徐砚通 王伟玲 王停 《中华中医药杂志》 CAS CSCD 北大核心 2022年第12期6944-6951,共8页
目的:观察补肾促孕方(BCR)对环磷酰胺(CTX)导致子宫内膜损伤的保护作用,并且分析其药效成分。方法:SD大鼠腹腔注射CTX后分组灌胃给药,计算各组大鼠子宫指数,检测血清雌二醇(E_(2))水平,子宫内膜厚度及子宫内膜腺体数目,观察胚胎着床情... 目的:观察补肾促孕方(BCR)对环磷酰胺(CTX)导致子宫内膜损伤的保护作用,并且分析其药效成分。方法:SD大鼠腹腔注射CTX后分组灌胃给药,计算各组大鼠子宫指数,检测血清雌二醇(E_(2))水平,子宫内膜厚度及子宫内膜腺体数目,观察胚胎着床情况。运用UHPLC-LTQ-Orbitrap MS技术检测BCR的化学成分,结合药效与文献分析其药效成分。结果:与正常对照组比较,CTX组大鼠子宫指数有下降的趋势,血清E_(2)水平显著下降(P<0.05),子宫内膜厚度显著变薄(P<0.05),子宫内膜腺体数目、总胚胎数目及活胚数目均有减少的趋势;与CTX组比较,BCR组大鼠子宫指数有升高的趋势,血清E_(2)水平显著升高(P<0.05),子宫内膜厚度显著增厚(P<0.05),子宫内膜腺体数目、总胚胎数目及活胚数目有增加的趋势。BCR中共鉴定出84种化学成分,其药效成分推测主要集中于黄酮类。结论:补肾促孕方能够改善子宫内膜容受性,其药效成分推测为槲皮素和山柰酚等。 展开更多
关键词 补肾促孕方 子宫内膜容受性 环磷酰胺 药效 药效成分
原文传递
中西医结合治疗排卵障碍性疾病132例临床观察
4
作者 侯小青 凌浩晋 李伟 《中国初级卫生保健》 2005年第6期69-70,共2页
目的观察中西医结合治疗排卵障碍性疾病的疗效。方法对132例排卵功能障碍性患者随机分为2组,实验组用补肾促孕方加克罗米酚(CC)/绒毛膜促性缴素(HCG)治疗。对照组用CC/HCG治疗。结果实验组的受孕率为63.41%,黄体功能不足的发生率(LPD)为... 目的观察中西医结合治疗排卵障碍性疾病的疗效。方法对132例排卵功能障碍性患者随机分为2组,实验组用补肾促孕方加克罗米酚(CC)/绒毛膜促性缴素(HCG)治疗。对照组用CC/HCG治疗。结果实验组的受孕率为63.41%,黄体功能不足的发生率(LPD)为19.51%,未破裂卵泡黄素化(LUF)的发生率为7.32%,对照组的受孕率为36.84%,LPD的发生率为34.21%.LUF为15.79%,实验组的受孕率明显高于对照组(P<0.05),LPD、LUF的发生率均明显低于对照组(p<0.05)。结论用补肾促孕方加CC/HCG治疗排卵障碍性疾病疗效较好。 展开更多
关键词 诱发排卵 补肾促孕方 克罗米酚 绒毛膜性腺激素
下载PDF
Clinical Effects of Bushen Culuan Prescription on Infertility Due to Decreased Ovarian Reserve of Kidney Deficiency and Liver Depression Pattern
5
作者 Yanqi Feng Sujuan Ma 《Chinese Medicine and Natural Products》 2022年第3期152-157,共6页
Objective The objective of this study was to explore the clinical effects of Bushen Culuan prescription on infertility due to decreased ovarian reserve of kidney deficiency and liver depression pattern.Methods Totally... Objective The objective of this study was to explore the clinical effects of Bushen Culuan prescription on infertility due to decreased ovarian reserve of kidney deficiency and liver depression pattern.Methods Totally 100 infertile patients with ovarian hypofunction treated from October 2019 to January 2022 were selected and divided into the observation group and the control group by a random number table.The control group was treated with estrogen sequential therapy,and the observation group was treated with Bushen Culuan prescription.The clinical efficacy,sex hormone levels including(follicle-stimulating hormone[FSH],luteinizing hormone[LH],and estradiol[E_(2)]),ovarian function,ovarian blood flow status(peak systolic velocity[PSV],antral follicle count[AFC],arterial pulse index[PI],and resistance index[RI]),and pregnancy outcome in the two groups were compared and analyzed.Results The total effective rate of the observation group(96.00%)was significantly higher than that of the control group(80.00%).The difference was statistically significant(p<0.05).Before treatment,there was no significant difference in sex hormone levels(FSH,LH,E_(2),and FSH/LH),ovarian function(number of primary follicles,number of dominant follicles,ovulation number,and endometrial thickness),and ovarian blood flow(PSV,RI,PI,and AFC)between the two groups(p>0.05).After treatment,the levels of serum hormones FSH,LH,E_(2),and FSH/LH decreased significantly in both groups.The number of primary follicles,dominant follicles,and ovulation increased significantly,and the thickness of endometrium decreased significantly;the indexes of PSV,RI,and AFC of ovarian blood flow increased significantly,and the PI index decreased significantly.The levels of each index in the observation group were better than those in the control group(p<0.05).In the control group,32 cases were pregnant within 1 year after treatment,and the pregnancy rate was 64.00%;21 cases in the observation group were pregnant within 1 year after treatment,and the pregnancy rate was 42.00%;the pregnancy rate in the observation group was higher than that in the control group,and the difference was statistically significant(χ^(2)=4.014,p=0.045<0.05).Conclusion Bushen Culuan prescription has a definite effect on infertility due to ovarian hypofunction.The action mechanism may involve multicomponent and multitarget stimulation to improve patients'ovarian function,regulate the level of sex hormones,and improve the pregnancy outcome. 展开更多
关键词 INFERTILITY Bushen Culuan prescription ovarian hypofunction estrogen sequential therapy
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部